/newsroom/taxonomy/term/9334/all en /newsroom/channels/news/stomach-bug-may-raise-your-risk-alzheimers-disease-353663 <p><!-- x-tinymce/html --></p> <p>A common stomach bacteria found in two thirds of the world population may be linked to a higher risk of Alzheimer’s disease, new research suggests.</p> Mon, 18 Dec 2023 19:27:57 +0000 keila.depape@mcgill.ca 307557 at /newsroom /newsroom/channels/news/more-convenient-and-accessible-way-diagnose-alzheimers-disease-347880 <p>Despite extensive research and encouraging findings, Alzheimer’s disease (AD) remains difficult to diagnose based on signs and symptoms alone. But what if one day, a blood sample during an annual check-up could be used to identify the disease? A <a href="https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.13026">recent ƻ����Ժ-led study</a> has found that a new kind of blood test is as effective at detecting AD as lumbar punctures, one of the current methods used to diagnose AD.</p> Thu, 20 Apr 2023 13:46:35 +0000 frederique.mazerolle@mcgill.ca 298503 at /newsroom /newsroom/howard-bergman Tue, 21 Jun 2022 18:38:35 +0000 shirley.cardenas@mcgill.ca 288213 at /newsroom /newsroom/channels/news/experts-fda-approves-much-debated-alzheimers-drug-panned-experts-331414 <p>U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration (FDA) said it granted approval to the drug from Biogen based on results that seemed “reasonably likely” to benefit Alzheimer's patients. (<a href="https://www.ctvnews.ca/health/fda-approves-much-debated-alzheimer-s-drug-panned-by-experts-1.5459470" target="_blank">CTV News</a>)</p> Tue, 08 Jun 2021 20:48:35 +0000 frederique.mazerolle@mcgill.ca 269362 at /newsroom /newsroom/channels/news/not-being-aware-memory-problems-predicts-onset-alzheimers-disease-285116 <p>Doctors who work with individuals at risk of developing dementia have long suspected that patients who do not realize they experience memory problems are at greater risk of seeing their condition worsen in a short time frame, a suspicion that now has been confirmed by a team of ƻ����Ժ clinician scientists.</p> Thu, 15 Feb 2018 15:02:05 +0000 justin.dupuis@mcgill.ca 32964 at /newsroom /newsroom/channels/news/non-invasive-method-detect-alzheimers-disease-283481 <p>New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.</p> <p>Scientists have known for some time that one of the first signs of AD is buildup of amyloid-Beta and tau proteins in the brain. They have also known that the hippocampus atrophies and loses volume in some AD patients years before cognitive decline.</p> Tue, 19 Dec 2017 19:21:00 +0000 priya.pajel@mail.mcgill.ca 32807 at /newsroom /newsroom/channels/news/artificial-intelligence-predicts-dementia-onset-symptoms-269722 <p>Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care. Thanks to artificial intelligence research conducted at ƻ����Ժ, this kind of predictive power could soon be available to clinicians everywhere.</p> Tue, 22 Aug 2017 14:16:47 +0000 justin.dupuis@mcgill.ca 32189 at /newsroom /newsroom/serge-g-gauthier Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 23518 at /newsroom